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The field of nanotechnology is an inten-
sively developing field as a result of its wide-
ranging applications in different areas of science
and technology. The term nano technology is
defined as the creation, exploitation and syn-
thesis of materials at a scale of 1–100 nm
(1 nm = 10–9 m). The word «nano» is derived
from a Greek word meaning «dwarf» or
«extremely small». Nanobiotechnology is a
multidisciplinary field and involves research
and development of technology in different
fields of science like biotechnology, nanotech-
nology, physics, chemistry, and material sci-
ence [1, 2].
Nanoparticles (NPs) exhibit different
shapes like spherical, triangular, rod, etc.
(Fig. 1). Research on nanoparticles’ synthesis
is the current area of interest due to the
unique visible properties (chemical, physical,
optical, etc.) of nanoparticles compared with
the bulk material [3, 4].
Nanoparticles have broad application
prospects in biology and medicine [6–10].
Since many microorganisms seem to be less
sensitive to most of the antibiotics, resear -
chers started finding a new potential antimi-
crobial agent. With this respect, silver and sil-
ver-based compounds are having strong bacte-
riocidal and fungicidal activity [11].
Nanoparticles having larger surface area
to volume ratio tend to pose higher antimicro-
bial activity [12]. Also, silver has a lower
propensity to stimulate microbial resistance
than many other antimicrobial agents [11].
Based on these properties, silver nanoparticles
(Ag-NPs) have been used in wide range of
applications such as to prevent infection, in
(burn and traumatic) wound dressings, diabe -
tic ulcers, coating of catheters, dental works,
scaffold, and medical devices [13, 14].
Nanotechnology is an integration of diffe -
rent fields of science which holds promise in
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Nowadays, the value of bactericidal nanomaterials research increases at the increasing number of bac-
teria strains resistant to the most highly potent antibiotics. In the review the characteristic of nanopar-
ticles and methods for their production are done. The scope of nanoparticles application is observed, spe-
cial attention is focused on silver nanoparticles usage in medicine, in particular, as bactericidal products.
It is indicated that nanoparticles may have toxic effects.
Much attention is paid to nanoparticles application in the treatment of various diseases, for example,
for targeted drug delivery, wound healing, bone regeneration, local heating of tumors in cancer patholo-
gy, immune system stimulation, for antibodies, viruses, bacteria detection, for liquids filtration.
Penicillins and their producers — Penicillium sp. characteristic is done. The mechanism of penicillin
antimicrobial action is estimated. 
It is revealed that silver nanoparticles usage in combination with antibiotics, particularly penicillin,
leads to antibiotics antibacterial activity increasing against gram-positive and gram-negative microor-
ganisms.
Fig. 1. Silver nanoparticles with a diameter of
10–15 nanometers coat nylon nanofibers with 
a diameter of approximately 80 nanometers.
Photo: Cornell University Textiles [5]
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the pharmaceutical industry, medicine,
biotechnology and agriculture [2]. The unique
properties of nanoparticles different from the
bulk material have attracted the attention of
several workers to use the multiple functiona -
li ties of nanoparticles. For example, the infor-
mation about silver nanoparticles for water
treatment and microbiological control was
given at VII International Scientific confe -
rence of students and PhD Students «Youth
and Progress of Biology» [15].
Silver NPs may exhibit antibacterial activ-
ity [16]. Furthermore, silver NPs were shown
to enhance the antibacterial activity of such
biotechnological products as penicillin G,
amoxicillin, erythromycin, clindamycin, and
vancomycin against Staphylococcus aureus
and Escherichia coli [17].
Silver as a biocide
Nanotechnology offers opportunities to re-
explore the biological properties of already
known antimicrobial compounds by manipu-
lating their size to alter the effect. Silver has
long been known for its antimicrobial proper-
ties, but its medical applications declined with
the development of antibiotics. Silver (Ag) is a
transition metal element having atomic num-
ber 47 and atomic mass 107.87. The medicinal
uses of silver have been documented since
1000 B.C. Silver is a wellness additive in tradi-
tional Chinese and Indian Ayurvedic medicine
[18]. Its action as an antibiotic comes from the
fact that it is a non-selective toxic «biocide».
Silver based antimicrobial biocides are used as
wood preservatives. In water usage, silver and
copper based disinfectants are used in hospital
and hotel distribution systems to control
infectious agents (for example, Legionella). 
Nanomaterials can be toxic at the cellular,
organ, and organism levels [19]. Cytotoxic
effects of carbon nanotubes may be due to their
ability to generate reactive oxygen species. The
cytotoxic effect is due to oxidative damage of
proteins, lipids and DNA, which in turn
increases oxidative stress in cells and leads to
their death by apoptosis or necrosis [8].
In medicine the most widely used are silver
nanoparticles. Colloidal silver containing
medicines collargol and protargol are pro-
duced since 1902 till nowadays. Except for
nanosilver, nanogold, nanocopper, nanooxides
of silicium, titanium, iron and zinc, calcium
phosphate and hydroxyapatite ceramic
nanoparticles, nanoparticles of polymers
(polystyrene, latex, chitosane, cyclodextrin)
are used [20].
Currently, silver sulfadiazine is listed by
the World Health Organization as an essential
anti-infective topical medicine [21]. Since sil-
ver works as a bulk material, the use of nano-
size silver may also be appealing.
Methods of nanoparticle synthesis
Owing to the wide range of nanoparticles
applications in different fields of science and
technology, different protocols have been
designed for their synthesis [13]. The
nanoparticles can be synthesized using the
top-down (physical) approach which deals with
methods such as thermal decomposition, dif-
fusion, irradiation, arc discharge, etc., and
bottom-up (chemical and biological) approach
which involves seeded growth method, polyol
synthesis method, electrochemical synthesis,
chemical reduction, and biological entities for
fabrication of nanoparticles by means of
biotechnological methods. Different synthesis
methods involve the use of different types of
chemical, physical, and biological agents to
yield nanoparticles of different sizes and
shapes [3].
Physical methods used for the synthesis of
nanoparticles include thermal decomposition,
laser irradiation, electrolysis, condensation,
diffusion, etc. The thermal decomposition
method is used for the synthesis of monodis-
perse nanoparticles. Fatty acids are dissolved
in hot NaOH solution and mixed with metal
salt solution which leads to formation of metal
precipitate [22]. In diffusion method, crystals
and short wires of copper are enclosed in glass
ampoules and sealed at low pressure; further,
the ampoules are annealed at 500 °C for 24 h.
The crystals are removed from the ampoules
and cooled on a metallic plate at room tempe -
rature. In the UV irradiation technique, poly-
carbonate films are cut and placed on glass
microscope slide and exposed to UV radiation
which results in the formation of hydroxyl
groups on polycarbonate films. Further, these
polycarbonate films are silanized with 3-
(aminopropyl) triethoxysilane (APS) in dena-
tured ethanol for 2 h and rinsed with deionised
water which leads to the formation of silver
film on the polycarbonate film [23]. The arc-
discharge method involves use of two graphite
electrodes which act as cathode and anode and
are immersed in metal salt solution. The elec-
trodes are brought in contact to strike an arc
and separated immediately to sustain arc
inside salt solution. The synthesis of nanopar-
ticles is carried out at an open circuit and an
optimized direct current [24].
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The most often used method for the chemi-
cal synthesis of nanoparticles is the chemical
reduction method, which deals with the reduc-
tion of metal particles to nanoparticles using
chemical reducing agents like sodium borohy-
dride or sodium citrate [25]. Other chemical
agents utilized for the synthesis are N,N-
dimethyl formamide (DMF), poly(N-vinyl
pyrrolidine) (PVP), ethyl alcohol, tetra-n-
tetrafluoroborate (TFATFB), etc. [26, 27].
Seeded growth method is a colloid chemical
method for the synthesis of nanoparticles
which involve preparation of seeds by redu -
cing metal ions with the suitable reducing
agent. The fine particles so formed are called
seed particles which are then added to growth
solutions containing metal ions and additives
like L-ascorbic acid and hexadecyltrimethyl -
ammonium bromide (CTAB) [27]. Polyol is
also used in the synthesis of nanoparticles. In
the polyol method a metal precursor is dis-
solved in a liquid polyol in the presence of cap-
ping agent. The metal sol is prepared using
methanol or ethyl alcohol as a solvent and
reducing agent while PVP is used as a protec-
tive and capping agent [26]. Electrochemical
synthesis method induces chemical reactions
in an electrolyte solution with the use of an
applied voltage. A wide variety of nanomate -
rials could be synthesized using this method.
Biological agents used for the synthesis of
nanoparticles include mainly bacteria, fungi
[28, 29] and plants [30–33]. The biotechnolo -
gical methods used for the synthesis of
nanoparticles include both extracellular and
intracellular methods [2, 34, 35]. The synthe-
sis of nanoparticles using bacteria and actino-
mycetes usually involves the intracellular syn-
thesis method, in which the bacterial cell
filtrate is treated with metal salt solution and
kept in a shaker in dark at ambient tempera-
ture and pressure conditions [36]. For the
extracellular synthesis of nanoparticles using
bacteria, the bacterial culture is centrifuged
at 8,000g and the supernatant is challenged
with metal salt solution [37]. In case of fungi
also nanoparticles are intracellularly synthe-
sized by treating the fungal mycelium with
metal salt solution and further incubation for
24 h [38]. Dried mycelium of fungi is also used
for synthesis of nanoparticles. In this method
the fungal mycelium is harvested by centrifu-
gation and subsequently freeze dried, and this
freeze-dried mycelium is immersed in metal
salt solution and kept on a shaker [39].
However, in the extracellular method the fil-
trate of the mycelium is treated with metal
salt solution and incubated for 24 h [40, 41].
In algal synthesis of nanoparticles washed cul-
ture of algae without the presence of any me -
dium is treated with metal salt solution and
kept in dark with controlled pH and tempera-
ture conditions [42, 43]. The biotechnological
synthesis of nanoparticles using yeast
involves two steps which include firstly the
synthesis of nanoparticles and next recovery
of the synthesized nanoparticles [43]. For the
synthesis process, yeast culture is challenged
with metal salt solution and incubated in dark
for 24 h. Further, the cells are separated from
the medium by centrifugation and the cell-free
extract is used for recovery of nanoparticles.
For recovery of nanoparticles, specifically
designed apparatus (polycarbonate bottle with
sampling cup) is used, which separates nano -
particles from the extract by differences in
thawing temperature. The cell-free medium
containing nanoparticles is filled in the bottle
up to the brim and kept at 20 °C in upright
position. During freezing, the nanoparticles
get denser than medium and settle down. The
bottle is then kept at 0° C and allowed to thaw.
The concentrated colloidal solution obtained
in the sampling cup is centrifuged at 23,000 g
for 24 h, the particles are suspended in dis-
tilled water, and further the particles are
dried in vacuum [42]. 
Fields of application
Nanotechnology is an integration of diffe -
rent fields of science which holds promise in
the pharmaceutical industry, medicine, bio -
tech nology and agriculture [44]. The unique
pro perties of nanoparticles different from the
bulk material have attracted the attention of
several workers to harness the multiple func-
tionalities of nanoparticles.
Silver nanoparticles are utilized in the area
of electronics, e.g. silica-coated Ag nanowires
for electric circuits [45].
Colloidal silver nanoparticles can be used
in the treatment of cancer and arthritis.
In cancer therapy it is proposed to use car-
bon nanotubes for the transport of drugs to
the cancer cells [7], for DNA oligonucleotides
transport to the nuclei of cancer cells for their
selective destruction without damaging of
normal cells [8]. In addition, carbon nanotubes
by irradiation in the infrared are heated, due
to this hyperthermic therapy of tumors is pos-
sible [46]. 
Fullerenes are biologically active and non-
toxic, they are able to penetrate biological
membranes, exhibit strong antioxidant and
antiviral properties, increase the protective
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functions of the immune system, and prevent
the growth of malignant tumors. Metallo fulle -
renes penetrate the plasma membrane of the
tumor cells and effectively inhibit their prolife -
ration, inhibit the vascularization of tumors
and therefore prevent their malignancy, reduce
metastasis. Their effect may be explained by
their high antioxidant activity and blocking of
specific cell receptors [9, 10, 47–49].
Detection of viruses is generally per-
formed by either antigens (immunoassays) or
genome sequences (polymerase chain reaction-
based methods). However, sensitivity of such
detection techniques is a problematic issue.
There is novel sandwich-enzyme immunosor-
bent method for direct detection of adeno -
viruses with the help of covalently coated
monoclonal anti-hexon antibodies onto highly
fluorescent europium (III)-chelate doped
nanoparticles (~107 nm).
Carbon nanotubes are offered to use for
antibodies detection, including the cases of
autoimmune diseases, for the detection of
nucleotide sequences, as ion channel blockers,
as biosensors for detection of DNA, glucose,
cholesterol, and nitric oxide [7].
The technique of nanofiltration is a novel
method to remove both enveloped and non-
enveloped viruses [50]. There are reports of
removal of IgG-coated non-enveloped viruses
including bovine parvovirus and bovine
enterovirus with the help of 20- and 50-nm-
sized nanofilters [51].
Nanoparticles due to its biocompatibility
and strong interaction with bases like thiols
play a major role in the treatment of cancer
[52]. Epithelial ovarian cancer a common
malignancy of female genital tract could be
cured with the use of gold nanoparticles.
Vascular endothelial growth factor (VEGF)
performs a vital role in the progression of
ovarian cancer and also tumor growth and gold
nanoparticles possess the capability to inhibit
the progression of ovarian tumor growth and
metastasis. Also, in case of multiple myeloma
(MM), a cancer of plasma cells, nanoparticles
are observed to inhibit the function of VEGF
which induces cell proliferation. This inhibi-
tion of VEGF further leads to upregulation of
cell cycle inhibitor proteins like p21 and p27
which inhibit proliferation [52].
Chronic lymphocytic leukemia (CLL), a
cancer caused due to the overproduction of
lymphocytes. Chronic leukemia starts in the
bone marrow but could spread to other organs
also. Nanoparticles possess the ability to
inhibit the function of growth factor secreted
by CLL cells, and induce apoptosis [52].
Rheumatoid arthritis which is considered
as an incurable disease, bare nanoparticles are
found to serve as a possible cure. 
Nanoparticles can be used in the construc-
tion of miniaturized devices, which can be
helpful in drug delivery [6, 7, 53].
Thiol-stabilized nanoparticles are used as
«bio-catalyst». Nanoparticles can be used as
fluorescence labeling system in microbial
detection. Nanoparticles can be widely used as
signal reporters to detect biomolecules in DNA
assay, immunoassay and cell bioimaging [54].
It is prospectively to use carbon nanotubes
as mechanically strong micro catheters that do
not affect coagulation parameters [7].
Catheters coated with nanocrystalline sil-
ver serve as a tool to prevent infections. Silver
nanoparticles are found to be active against
most of the nosocomial infections related to
catheters and also predominantly accumulate
at the site of insertion. Thus, silver nanoparti-
cles function as a protective agent against
infection has no risk of systemic toxicity [55].
Nanosilver dressings are found to induce
major improvements in the healing of wounds
with respect to antimicrobial efficiency, ease
in using and faster re-epithelialization. It was
reported that re-epithelialization in a patient
with a third-degree burn was observed as a
result of the treatment of nanosilver dressing
as it provided a protection against infections
and also promoted early formation of neoder-
mis and uncomplicated wound closure [3, 56].
Titanium nanoparticles are particularly
useful for the production of pigments, paints
and cosmetics [57].
The bone cells interact with nanostruc-
tured materials as the collagen fibrils, hydro -
xyapatite and proteoglycans found in bone tis-
sues in the nanometer scale. Hence,
nanomaterials are efficiently used for the
regeneration and repair of bone tissues. It is
observed that the bone cells could elicit desired
cellular functions like adhesion, migration
and proliferation. Nanomaterials can mimic
the constituent components of bone, may be
used for bones and neurons growing [7, 58].
Examples of bone implants include nanoce-
ramics, nanopolymers, nanometals and com-
posites [59].
Characteristics of penicillin 
and Penicillium spp.
Penicillin (sometimes abbreviated PCN or
pen) is a group of antibiotics derived from
Penicillium fungi (Fig. 2). They include peni-
cillin G, procaine penicillin, benzathine peni-
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cillin, and penicillin V. Penicillin antibiotics
are historically significant because they are
the first drugs that were effective against
many previously serious diseases such as
syphilis and infections caused by staphylococ-
ci and streptococci. Penicillins are still widely
used today, though many types of bacteria are
now resistant. All penicillins are beta-lactam
antibiotics and are used in the treatment of
bacterial infections caused by susceptible,
usually Gram-positive, organisms [60].
Bacteria constantly remodel their peptido-
glycan cell walls, simultaneously building and
breaking down portions of the cell wall as they
grow and divide. β-Lactam antibiotics inhibit
the formation of peptidoglycan cross-links in
the bacterial cell wall, but have no direct effect
on cell wall degradation. The β-lactam moiety
(functional group) of penicillin binds to the
enzyme (DD-transpeptidase) that links the
peptidoglycan molecules in bacteria. The
enzymes that hydrolyze the peptidoglycan
cross-links continue to function, which weak-
ens the cell wall of the bacterium (in other
words, the antibiotic causes cytolysis or death
due to osmotic pressure). In addition, the
build-up of peptidoglycan precursors triggers
the activation of bacterial cell wall hydrolases
and autolysins, which further digest the bac-
teria’s existing peptidoglycan. This imbalance
between cell wall production and degradation
is responsible for the rapid cell-killing action
of this class of drugs, even in the absence of
cell division. In addition, the relatively small
size of the penicillin molecule allows it to pene -
trate deeply into the cell wall, affecting its
entire depth. This is in contrast to the other
major class of cell wall synthesis inhibiting
antibiotics, the glycopeptide antibiotics (which
includes vancomycin and teicoplanin) [61].
Penicillin shows a synergistic effect with
aminoglycosides, since the inhibition of pepti-
doglycan synthesis allows aminoglycosides to
penetrate the bacterial cell wall more easily,
allowing its disruption of bacterial protein
synthesis within the cell.
Penicillin is a secondary metabolite of fun-
gus Penicillium that is produced when growth
of the fungus is inhibited by stress. It is not
produced during active growth. Production is
also limited by feedback in the synthesis path-
way of penicillin [61]: 
α-ketoglutarate + AcCoA → homocitrate →
→ L-α-aminoadipic acid → L-Lysine + β-lactam.
The by-product L-Lysine inhibits the pro-
duction of homocitrate, so the presence of
exogenous lysine should be avoided in peni-
cillin production [62].
The Penicillium cells are growing using a
technique called fed-batch culture, in which
the cells are constantly subject to stress,
which is required for induction of penicillin
production. The carbon sources that are
availab le are also important: glucose inhibits
penicillin production, whereas lactose does
not. The pH and the levels of nitrogen, lysine,
phosphate, and oxygen of the batches must
also be carefully controlled [61]. 
The biotechnological method of directed
evolution has been applied to produce by muta-
tion a large number of Penicillium strains.
Appropriate techniques include PCR, DNA
shuffling etc. [62]. 
Penicillium is a genus of ascomycetous
fungi of major importance in the natural envi-
ronment as well as food and drug production
(Fig. 3). It produces penicillin, a molecule that
Fig. 2. Laboratory Petri-dish culture of the fun-
gus Penicillium chrysogenum growing on agar
with the produced antibiotic penicillin.
Geoff Tompkinson/Science Photo Library [5]
Fig. 3. Penicillium chrysogenum, coloured scanning
electron micrograph (SEM) at magnification ×1250.
The round structures are conidia, the asexual
reproductive spores of the fungus. Eye of
Science/Science Photo Library [5].
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is used as an antibiotic, which kills or stops the
growth of certain kinds of bacteria inside the
body. The widespread genus contains over 300
species [63].
Penicillium is classified as a genus of
anamorphic fungi in the division Ascomycota
(order Eurotiales, class Eurotiomycetes, fami-
ly Trichocomaceae) [64]. The genus name is
derived from the Latin root «penicillium»,
meaning «painter’s brush», and refers to the
chains of conidia that resemble a broom [65].
The thallus (mycelium) typically consists
of a highly branched network of multinuc -
leate, septate, usually colorless hyphae. Many-
branched conidiophores sprout on the mycelia,
bearing individually constricted conidio -
spores. The conidiospores are the main disper-
sal route of the fungi, and often green.
Sexual reproduction involves the produc-
tion of ascospores, commencing with the
fusion of an archegonium and an antheridium,
with sharing of nuclei. The irregularly distri -
buted asci contain eight unicellular ascospores
each [66].
Combined action of penicillin 
and nanoparticles
With the emergence and increase of micro-
bial organisms resistant to multiple anti bio -
tics, and the continuing emphasis on health-
care, many researchers have tried to develop
new, effective antimicrobial reagents free of
resistance. Such problems and needs have led
to the resurgence in the use of Ag-based anti-
septics that may be linked to broad-spectrum
activity and far lower propensity to induce
microbial resistance than antibiotics [67].
Research in antibacterial material containing
various natural and inorganic substances has
been intensive [68]. Among metal nanoparti-
cles (Me-NPs), silver nanoparticles (Ag-NPs)
have been known to have inhibitory and bacte-
ricidal effects. It can be expected that the high
specific surface area and high fraction of sur-
face atoms of Ag-NPs will lead to high antimi-
crobial activity as compared with bulk silver
metal [68]. The biomedical application of sil-
ver nanoparticles also attracted increasing
interest, such as antimicrobial activity of sil-
ver nanoparticles for wound healing, and sil-
ver nano-coated medical devices, etc. [69].
There were investigated that silver ion or
metallic silver as well as silver nanoparticles
can be exploited in medicine for burn treat-
ment, dental materials, coating stainless steel
materials, textile fabrics, water treatment,
sunscreen lotions, etc. and posses low toxicity
to human cells, high thermal stability and low
volatility [70].
In 2007, three papers have been published
reporting the use of blue aggregated mixtures
of drugs and NPs, rather than of stable red
conjugates [71–73]. Such a color change and
transmission electron microscopy (TEM)
images unambiguously indicated NP aggrega-
tion. The drugs used were aminoglycoside
antibiotics (streptomycin, gentamicin, kana -
my cin, and neomycin), quinolones (cipro flo xa -
cin, gatifloxacin, and norfloxacin), ampicillin
(a penicillin antibiotic), and 5-fluorouracil (an
antimetabolite of nucleic metabolism). The
preparations were tested for antibacterial
activity toward gram-positive (Bacillus subtilis,
Staphylococcus aureus, Micrococcus luteus) and
gram-negative (E. coli, Pseudo monas aerugi-
nosa) microorganisms and they also were exam-
ined for antifungal activity toward Aspergillus
fumigatus and Aspergillus niger (Fig. 4, 5). The
basic experimental tests for the determination
of antibacterial activity were the disk diffusion
method and the agar diffusion method.
Depending on the antibiotic used, increase in
the activity of the antibiotic-colloidal-silver
mixture ranged from 12 to 40%, as compared
with the activities of the native drugs. So, the
antibacterial activities of the antibiotics were
enhanced through the use of silver NPs.
Fig. 4. Coloured scanning electron micrograph
(SEM) of Bacillus subtilis bacteria 
at magnification ×12000.
Steve Gschmeissner/Science Photo Library [5]
Fig. 5. Coloured scanning electron micrograph
(SEM) of Staphylococcus aureus bacteria 
at magnification ×16000.
Eye of Science/Science Photo Library [5]
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Nowadays one of the nanobiotechnology
tasks is metal nanoparticles construction and
usage. Nanoparticles are known for a long
time, and they are used in different areas of
human activity. Silver nanoparticles have a
wide range of applications in pharmacy, medi-
cine, biotechnology and agriculture. From the
literature data analyzing there was given
information about nanotechnology develop-
ment in face of silver nanoparticles in the com-
bination with antibiotics. Silver nanoparticles
are in active usage as «naked» as in the combi-
nation with antibiotics, in particular with
penicillin, for enhancing of their action. The
silver nanoparticles can be synthesized by the
means of physical, chemical and biological
methods. Penicillin produced by filamentous
fungi Penicillium sp. is the first discovered
antibiotic; it is still applied in medicine. But
many bacteria for the long time have deve -
loped the resistance to it. Researches show
that penicillin in the combination with the sil-
ver nanoparticles give the highly effective
bactericidal action against different bacteria,
especially Bacillus subtilis and Staphylococcus
aureus.
Nanobiotechnology is prospective for me -
dicine. Nanocomposites creation and applica-
tion are especially important. Nanoparticles
usage offers great opportunities for diagno -
stics and treatment patients with bone and
joint patho logy, bacterial and virus in -
fections, injuries, autoimmune diseases, can-
cer, etc.    
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На цей час зростає значення досліджень
бактерицидних наноматеріалів у зв’язку зі
збільшенням кількості штамів бактерій,
резистентних до більшості сильнодійних
антибіотиків. В огляді подано характеристи-
ку наночастинок і способів їх одержання.
Розглянуто галузі застосування наночасти-
нок, особливу увагу приділено використан-
ню наночастинок срібла в медицині, зокрема
як бактерицидних препаратів. Зазна чено,
що наночастинки можуть справляти токсич-
ну дію.
Велику увагу приділено застосуванню
наночастинок в терапії різних захворювань,
наприклад, для спрямованого доставлення
ліків, загоєння ран, відновлення кісткової
тканини, локального нагрівання пухлин
при онкологічних захворюваннях, стимуля-
ції функцій імунної системи, для визначен-
ня антитіл, вірусів, бактерій, для фільтрації
рідин.
Наведено характеристику пеніцилінів та
їхніх продуцентів — Penicillium sр. Роз гля -
нуто механізм антимікробної дії пеніциліну.
Виявлено, що застосування наночасти-
нок срібла в комбінації з антибіотиками,
зокрема з пеніциліном, сприяє посиленню
антибактеріальної активності антибіотиків
стосовно грампозитивних і грамнегативних
мікроорганізмів.
Ключові слова: нанотехнологія, нано час тин ки
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В настоящее время возрастает значение
исследований бактерицидных наноматериа-
лов в связи с увеличением количества штам-
мов бактерий, резистентных к большинству
сильнодействующих антибиотиков. В обзоре
дана характеристика наночастиц и способов
их получения. Рассмотрены области приме-
нения наночастиц, особое внимание уделено
использованию наночастиц серебра в меди -
ци не, в частности в качестве бактерицидых
препаратов. Указано, что нано частицы мо -
гут обладать токсическим действием.
Большое внимание уделено применению
наночастиц в терапии различных заболева-
ний, например, для направленной доставки
лекарств, заживления ран, восстановления
костной ткани, локального нагрева опухо-
лей при онкологических заболеваниях, сти-
муляции функций иммунной системы, для
определения антител, вирусов, бактерий,
для фильтрации жидкостей.
Дана характеристика пенициллинов
и их продуцентов — Penicillium sр. Рассмот -
рен механизм антимикробного действия
пенициллина.
Установлено, что применение наночастиц
серебра в комбинации с антибио ти ками,
в частности с пенициллином, при во дит
к усилению антибактериальной актив ности
антибиотиков по отношению к грамположи-
тельным и грамотрицательным микроорга-
низмам.
Ключевые слова: нанотехнология, нано час ти -
цы серебра, антибиотики, пенициллин, Peni -
cil lium sp. 
